Manipal Health Enterprises IPO GMP Today: Date, Price, and Listing Date
Manipal Health Enterprises' ₹9,275.22 crore IPO opens on 29 July 2026. Here's a look at the latest GMP, price band, lot size, financials, reservation, and listing schedule.
Manipal Health Enterprises IPO GMP: The ₹9,275.22 crore IPO will open for subscription from 29 July to 31 July 2026. The IPO allotment is expected on 3 August 2026, and the shares are likely to be listed on BSE and NSE on 5 August 2026. The price band for the Manipal Health Enterprises IPO has been fixed between ₹560 and ₹590 per share.
Manipal Health Enterprises IPO: Incorporated in 2010, Manipal Health Enterprises is one of India's leading healthcare service providers. The company operates a large network of multi-specialty hospitals, clinics, and diagnostic centres across the country.
Through this IPO, the company aims to raise ₹9,275.22 crore via a combination of a fresh issue and an Offer for Sale (OFS). Here are the key details investors should know before applying.
Manipal Health Enterprises IPO Details
Here are the important dates and IPO details investors should know before applying.
-
Manipal Health Enterprises IPO is worth ₹9,275.22 crore and consists of a fresh issue of ₹8,000 crore and an Offer for Sale (OFS) of ₹1,275.22 crore.
-
The IPO will open for subscription on 29 July 2026 and close on 31 July 2026. And the price band has been fixed between ₹560 and ₹590 per share.
-
The IPO allotment is expected on 3 August 2026, and the shares are likely to be listed on BSE and NSE on 5 August 2026.
-
The promoters currently hold 81.43%, which is expected to reduce to 72.08% after the IPO.
-
Kfin Technologies Ltd. is the registrar, while Kotak Mahindra Capital Co. Ltd. is the book-running lead manager.
|
Parameter |
Detail |
|---|---|
|
IPO Open Date |
29 July 2026 |
|
IPO Close Date |
31 July 2026 |
|
Expected Allotment Date |
3 August 2026 |
|
Expected Listing Date |
5 August 2026 (BSE & NSE) |
|
Price Band |
₹560 - ₹590 per share |
|
Lot Size |
25 shares |
|
Minimum Investment |
₹14,750 |
|
Fresh Issue |
₹8,000 crore |
|
Offer for Sale (OFS) |
₹1,275.22 crore |
|
Total Issue Size |
₹9,275.22 crore |
Manipal Health Enterprises IPO GMP Today
Manipal Health Enterprises IPO GMP today (31 July 2026) stands at ₹4, indicating an estimated listing premium of 0.68% (as per investor gain website) over the upper price band of ₹590 in the grey market. The Grey Market Premium (GMP) has remained volatile over the past few days, reflecting changing investor sentiment ahead of the IPO opening.
GMP figures are provided for informational purposes only. We do not recommend trading in the grey market.
Investors should note that the Grey Market Premium (GMP) is unofficial and is not regulated by SEBI. It only reflects informal market sentiment and should not be considered a reliable indicator of listing performance or future returns.
READ THIS ALSO: Lohia Corp IPO Allotment Status
Manipal Health Enterprises IPO Day 3 Subscription Status
Overall, Manipal Health Enterprises IPO subscribed 0.55 times on Day 3, as of 11:36 AM.
|
Date |
QIB (Ex Anchor) |
NII |
Retail |
EMP |
Total |
|---|---|---|---|---|---|
|
29 July (Day 1) |
0.15 |
0.08 |
0.27 |
0.95 |
0.15 |
|
30 July (Day 2) |
0.62 |
0.15 |
0.48 |
1.54 |
0.47 |
|
31 July (Day 3) |
0.70 |
0.19 |
0.58 |
1.82 |
0.55 |
Source: NSE, as of 31 July 2026, 11:36 AM
About Manipal Health Enterprises IPO
Manipal Health Enterprises Limited was incorporated in 2010 and is one of India's largest healthcare service providers. The company is part of the Manipal Group, founded by Dr. T. M. A. Pai, and operates an extensive network of multi-specialty hospitals, clinics, and diagnostic centres across the country.
The company provides tertiary and quaternary healthcare services across several specialities, including organ transplantation, oncology, cardiology, neurology, orthopaedics, preventive healthcare, and critical care. It combines advanced medical infrastructure with experienced healthcare professionals to deliver patient-centric care.
Manipal Health has expanded its presence through strategic acquisitions, partnerships, and continuous investments in medical infrastructure and digital healthcare. As of 31 March 2026, the company operated 49 hospitals with 13,037 licensed beds and 21 clinics across India.
The company employed 24,240 full-time employees as of 31 March 2026, including 11,048 nurses, 6,362 paramedics, and 6,830 administrative staff, supporting its nationwide healthcare operations.
Manipal Health Enterprises IPO Reservation
For the Manipal Health Enterprises IPO, the allocation has been divided among Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors (RIIs).
|
Investor Category |
Shares Offered |
|---|---|
|
QIB Investors |
Not less than 75% |
|
Retail Investors |
Not more than 10% |
|
NII (HNI) Investors |
Not more than 15% |
Manipal Health Enterprises IPO Lot Size
Retail investors can apply for a minimum of 1 lot, comprising 25 shares, requiring an investment of ₹14,750. The maximum retail application is 13 lots.
|
Application |
Lots |
Shares |
Amount (₹) |
|---|---|---|---|
|
Retail (Min) |
1 |
25 |
14,750 |
|
Retail (Max) |
13 |
325 |
1,91,750 |
|
S-HNI (Min) |
14 |
350 |
2,06,500 |
|
S-HNI (Max) |
67 |
1,675 |
9,88,250 |
|
B-HNI (Min) |
68 |
1,700 |
10,03,000 |
Manipal Health Enterprises IPO Financial Performance
Manipal Health Enterprises reported strong revenue growth during FY26. The company recorded ₹10,520.52 crore in total income compared to ₹8,362.79 crore in FY25. However, Profit After Tax (PAT) declined during the year, while EBITDA continued to improve.
|
Period Ended |
31 Mar 2026 |
31 Mar 2025 |
31 Mar 2024 |
|---|---|---|---|
|
Total Income (₹ Cr) |
10,520.52 |
8,362.79 |
6,265.17 |
|
EBITDA (₹ Cr) |
2,795.94 |
2,247.07 |
1,776.60 |
|
EBITDA Margin (%) |
27.05 |
27.26 |
28.79 |
|
PAT (₹ Cr) |
916.52 |
1,081.67 |
533.20 |
|
PAT Margin (%) |
8.87 |
13.12 |
8.64 |
|
ROCE (%) |
21.88 |
26.98 |
NA |
|
Total Borrowing (₹ Cr) |
10,553.43 |
4,766.83 |
3,943.98 |
Source: Manipal Health Enterprises IPO RHP
READ THIS ALSO: Indo-MIM IPO Allotment Status
Manipal Health IPO Peers Comparison
Among its peers, Manipal Health has the lowest EPS; higher EPS is always considered good.
|
Company |
EPS (Diluted) |
P/E (x) |
|---|---|---|
|
Manipal Health Enterprises |
7.67 |
— |
|
Apollo Hospitals Enterprise |
134.94 |
66.15 |
|
Fortis Healthcare |
13.80 |
70.22 |
|
Max Healthcare Institute |
14.76 |
74.55 |
Conclusion
Manipal Health Enterprises IPO is one of the largest healthcare IPOs in recent years. The company has built a strong nationwide hospital network, enjoys a recognised healthcare brand, and has delivered consistent revenue growth through expansion and strategic acquisitions. The IPO proceeds will primarily be used to reduce debt and acquire a minority stake in Sahyadri Hospitals, which could strengthen its long-term business.